100 participants
The Role of FGF23 and Asymmetric Dimethylarginine (ADMA) in Chronic Kidney Disease
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2011-03-17
- Start Date:
- 2011-03-31
Conditions
- Metabolic Diseases
- Chronic Kidney Disease
No Results Yet